Cardiac autonomic neuropathy in diabetes mellitus: Prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis

Postgraduate Medical Journal

Volumn 84, Issue 990, 2008, Pages 205-210

  Pappachan, J M ^a,c   Sebastian, J ^a   Bino, B C ^a   Jayaprakash, K ^a   Vijayakumar, K ^a   Sujathan, P ^a   Adinegara, L A ^b  

^a Kottayam Medical College   (India)

^b MELAKA MANIPAL MEDICAL COLLEGE   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PERIPHERAL NEUROPATHY; QT INTERVAL; RISK FACTOR; TEACHING HOSPITAL;

AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; RISK FACTORS;

EID: 42649133816     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.064048     Document Type: Article

References (28)

1. Pradeepa R, Deepa R, Mohan V. Epidemiology of diabetes in India - current perspective and future projections. J Indian Med Assoc 2002;100:144-8.
2. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab 2005;90:5896-903.
3. Gupta SB, Pandit RB. Silent myocardial ischaemia and cardiac autonomic neuropathy in diabetics. Indian Heart J 1992;44:227-9.
4. Jermendy G. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol 2003;40(Suppl 2):S370-4.
5. Veglio M, Borra M, Stevens LK, et al. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia 1999;42:68-75.
6. Mehta S, Mathur D, Chaturvedi M, et al. Incidence of cardiac autonomic neuropathy and its correlation with retinopathy, micro-albuminuria and glycated haemoglobin in non-insulin dependent diabetes mellitus. J Indian Med Assoc 2002;100:141-3.
7. Ewing DJ, Martyn CN, Young RJ, et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-8.
8. Nakagawa M, Takahashi N, Ooie T, et al. Development of a new method for assessing the cardiac baroreflex: response to downward tilting in patients with diabetes mellitus. Heart 2001;86:643-8.
9. Ducher M, Cerutti C, Gustin MP, et al. Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes? Diabetes Care 1999;22:388-93.
10. Balcioǧlu S, Arslan U, Türkoǧlu S, et al. Heart rate variability and heart rate turbulence in patients with type 2 diabetes mellitus with versus without cardiac autonomic neuropathy. Am J Cardiol 2007;100:890-3.
11. Liatis S, Marinou K, Tentolouris N, et al. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med 2007;24:1375-80.
12. Whitsel EA, Boyko EJ, Siscovick DS. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care 2000;23:241-7.
13. Tentolouris N, Katsilambros N, Papazachos G, et al. Corrected QT interval in relation to the severity of diabetic autonomic neuropathy. Eur J Clin Invest 1997;27:1049-54.
14. Jermendy G, Koltai MZ, Pogátsa G. QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathy. Acta Diabetol Lat 1990;27:295-301.
15. Yokoyama A. Prognostic significance of QT prolongation and autonomic nervous dysfunction in alcoholics with diabetes mellitus. Keio J Med 1993;42:141-8.
16. Astrup AS, Tarnow L, Rossing P, et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006;29:334-9.
17. Whitsel EA, Boyko EJ, Rautaharju PM, et al. Electrocardiographic QT interval prolongation and risk of primary cardiac arrest in diabetic patients. Diabetes Care 2005;28:2045-7.
18. Veglio M, Chinaglia A, Cavallo-Perin P. QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest 2004;27:175-81.
19. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes 2003;111:215-22.
20. Rutter MK, Viswanath S, McComb JM, et al. QT prolongation in patients with type 2 diabetes and microalbuminuria. Clin Auton Res 2002;12:366-72.
21. Rossing P, Breum L, Major-Pedersen A, et al. Prolonged QTc interval predicts mortality in patients with type 1 diabetes mellitus. Diabet Med 2001;18:199-205.
22. Cardoso CR, Salles GF, Deccache W. QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke 2003;34:2187-94.
23. Bellavere F, Bosello G, Fedele D, et al. Diagnosis and management of diabetic autonomic neuropathy. BMJ (Clin Res Ed) 1983;287:61.
24. Thi NN, Paries J, Attali JR, et al. High prevalence and severity of cardiac autonomic neuropathy in Vietnamese diabetic patients. Diabet Med 2005;22:1072-8.
25. Witte DR, Tesfaye S, Chaturvedi N, et al, EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 2005;48:164- 71.
26. Mangoni AA, Kinirons MT, Swift CG, et al. Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis. Age Ageing 2003;32:326-31.
27. Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab 1987;64:751-4.
28. Viswanathan V, Prasad D, Chamukuttan S, et al. High prevalence and early onset of cardiac autonomic neuropathy among South Indian type 2 diabetic patients with nephropathy. Diabetes Res Clin Pract 2000;48:211-16.